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1. Introduction 
Administration of orotate, an intermediate in py- 
rimidine nucleotide biosynthesis, has been shown to 
elevate the levels of acid soluble uracil [l-6] and 
cytosine nucleotides [S] in liver. Furthermore, ac- 
tivities of enzymes involved in the de novo synthesis 
of pyrimidine nucleotides increase following the ad- 
ministration of orotate; this has been demonstrated 
for aspartate carbamoyl transferase (EC 2.1.3.2) and 
dihydro-orotase (EC 3.5.2.3) in rat liver [7]. In 
yeast, a sequential induction of enzymes of pyrimi- 
dine biosynthesis by an intermediate of this pathway 
(dihydroorotate) was observed [8]. Elevated uracil 
nucleotide contents as well as an increased rate of 
uridylate biosynthesis in liver have been considered 
essential for the prevention of galactosamine-induced 
hepatitis by orotate [9, lo] . Data will now be pre- 
sented indicating that orotate administration leads to 
increased activities of the hepatic enzymes catalyzing 
the conversion of orotate to UMP. 
2. Experimental procedures 
Orotate was administered intraperitoneally to 
female Wistar rats (150 g) as one single dose of Tris- 
orotate (3 mmole/kg body weight) or as 6 injections 
of choline orotate (0.57 mmole/kg body weight each) 
over a period of 2 days [9]. Untreated animals served 
as controls. Inhibitors of protein and RNA synthesis, 
respectively, were administered intraperitoneally 15 
min before orotate treatment: cycloheximide (4 mg/kg 
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body weight), actinomycin D (0.5 mg/kg body weight, 
the same dose repeated 4 hr later), and D-galactos- 
amine-HCl(400 mg/kg body weight). 
The specific radiochemical assays of the hepatic 
activities of orotidine 5’-phosphate pyrophosphory- 
lase (EC 2.4.2.10) and orotidine 5’-phosphate de- 
carboxylase (EC 4.1.1.23) were performed as de- 
scribed previously [ 1 l] 
Alanine aminotransferase (EC 2.6.1.2) and L-iditol 
dehydrogenase (EC 1 .l .1.14) activities in liver were 
measured according to Bergmeyer and Bernt [ 121 and 
Gerlach and Hiby [ 131, respectively. Specific activi- 
ties of enzymes are given in international units at 25”. 
3. Results 
3.1. Orotate effect 
The activity of orotidine 5’-phosphate (OMP)- 
pyrophosphorylase was elevated 8 hr after adminis- 
tration of Tris-orotate (table 1); it remained constant 
between 8 and 24 hr after orotate injection. Under 
the same conditions the activity of OMP-decarboxy- 
lase (in untreated animals, 0.60 + 0.09 mU/mg pro- 
tein(YS.D.)) was also enhanced significantly (fig. 1). 
Six doses of choline orotate increased the activities 
of OMP-pyrophosphorylase and of OMP-decarboxy- 
lase by 43 and 47% (p < O.OOl), respectively. 
To exclude unspecific effects of orotate on en- 
zyme activities the hepatic activity of alanine amino- 
transferase and L-iditol dehydrogenase was monitored: 
in untreated rats their activities (* S.D.) were 718 f 
189 and 237 + 35 mU/mg protein, respectively. Eight 
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Table 1 
Time-dependent changes of OMP-pyrophosphorylase activity after i.p. 
injection of 3 mmole Tris-orotate per kg body weight. 
Time after orotate OMP-pyrophosphorylase 
injection activity 
(hr) (mU/mg protein + S.D.) (n) 
Increase 
as compared 
to controls 
(%) 
P 
0 (controls) 0.53 t 0.02 ( 5) _ _ 
3 0.56 f. 0.05 ( 4) 6 _ 
8 0.71 + 0.09(11) 34 <O.OOl 
12 0.69 -I 0.08 ( 4) 31 <0.002 
24 0.72 f 0.10 ( 4) 36 <0.002 
For further details see Experimental procedures. 
hr after application of Tris-orotate 801 + 86 and 234 
+ 5 mU/mg protein, respectively, were measured, 
the differences not being significant. 
3.2. Pretreatment with inhibitors of protein and RNA 
synthesis 
Cycloheximide completely suppressed the orotate- 
induced stimulation of OMP-pyrophosphorylase and 
OMP-decarboxylase (table 2, fig. 1). Furthermore, in 
animals pretreated with D-galactosamine or actinomy- 
tin D, OMP-pyrophosphorylase activity increased after 
orotate treatment by less than 9%. A similar and signi- 
ficant extent of suppression was also observed with 
OMP-decarboxylase. The inhibitors alone did not 
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Fig. 1. Time-dependent increase in OMP-decarboxylase ac- 
tivity by Tris-orotate. The increase in activity is expressed 
as % over untreated controls. The experimental conditions 
are the same as in table 2. 
cause significant alterations of the basal enzyme ac- 
tivities. Accordingly, cycloheximide was shown not 
to affect the incorporation of orotate into UTP in 
short-term experiments in vivo [ 141 .
4. Discussion 
Changes of in vitro activities of the enzyme cata- 
lyzing uridylate biosynthesis from orotate were found 
to parallel alterations of the rate of stimulated uri- 
dylate synthesis in vivo. The latter was measured as 
the increase of the sum of uracil nucleotides with 
time under conditions of depleted hepatic pools of 
uridine phosphates and UDP-hexoses and calculated 
to be 0.35 I.tmoles/g liver/hr in adult rats [ 151. Orot- 
ate administration increased this value significantly 
[lo] . OMP-pyrophosphorylase and OMP-decarboxy- 
lase activities are elevated about 2-fold in livers of 
young rats (10 days after birth) and of rats 5 days 
after partial hepatectomy [ 1 l] ; here, the rates of 
stimulated uridylate biosynthesis exceed those of 
adult animals by a factor of 2.3 and 1.7, respectively 
[ 111 . The prerequisites for the prevention of galactos- 
amine-induced hepatitis by orotate are a higher capa- 
city of uridylate biosynthesis and increased tissue 
contents of uracil nucleotides’ [lo] . Both result in 
part from the orotate-induced elevation of hepatic 
OMP-pyrophosphorylase and OMP-decarboxylase 
activities. 
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Table 2 
Suppression of the orotate effect on OMP-pyrophosphorylase 
and OMP-decarboxylase by cycloheximide. 
February 1972 
Treatment 
None (controls) 
Orotate 
Orotate 
+ cycloheximide 
OMP-pyrophosphorylase 
(mU/mg protein f SD.) (n) 
0.53 f 0.02 ( 5) 
0.71 * 0.09 (11) 
0.56 + 0.03 ( 5) 
OMP-decarboxylase 
(mU/mg protein f S.D.) (n) 
0.60 f 0.09 ( 5) 
0.94 f 0.08 (11) 
0.68 + 0.03 ( 5) 
The enzyme activities were determined 8 hr after i-p. injection of 3 mmole Tris-orotate per kg body weight. 4 mg cycloheximide 
per kg body weight had been injected intraperitoneally 15 min before orotate administration. Differences between controls and 
orotate treated animals and the suppression of the orotate effect by cycloheximide are significant for both enzymes (p< 0.002). 
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